LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
|
Date: |
Thursday, August 1, 2024 |
|
Time: |
8:00 a.m. U.S. EST |
|
Webcast: |
A replay of the conference call will be available on the investor relations website.
To participate in the live Q&A session, please register using this link to receive an email confirming your registration.
About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact:
Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll-free)
Media Contact:
Katie Savastano
corporate.communications@bauschhealth.com
(908) 927-1976
SOURCE: Bausch Health Companies Inc.
View the original press release on accesswire.com
View the original press release on accesswire.com
AURORA, Colo. , April 16, 2025 /PRNewswire/ -- AdvancedPCB is proud to announce the appointment of…
MONTREAL, April 16, 2025 /CNW/ - Professors Eric Déziel and Étienne Yergeau are leading two new…
Innovative platform to streamline crisis response, connect individuals to care, and provide real-time behavioral health…
SEOUL, South Korea, April 16, 2025 /PRNewswire/ -- Mezzion Pharmaceuticals, a global leader in the development…
Nation's Leading Infrared and Red-Light Sauna Franchise to Debut in Almaden in Spring 2026 SAN…
Clario's Advanced AI-Powered Platform Streamlines Clinical Document Processing to Facilitate Faster Drug Development Timelines PHILADELPHIA,…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
